43
Participants
Start Date
July 9, 2021
Primary Completion Date
February 28, 2025
Study Completion Date
August 31, 2025
Rivaroxaban
Oral tablet 15 mg twice daily for 24 months
Warfarin
Oral anticoagulant given as standard of care in the RISAPS trial to maintain a target INR of 3.5 (range 3.0-4.0) for 24 months
Epsom and St Helier University Hospitals NHS Trust, Epsom
Barts and the London Hospitals, Barts Health NHS Trust, London
Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Kings College Hospital NHS Foundation Trust, London
University College Hospitals NHS Foundation Trust, London
Queens Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford
University College London Hospitals
OTHER
Barking, Havering and Redbridge University Hospitals NHS Trust
OTHER
Hammersmith Hospitals NHS Trust
OTHER
Epsom and St Helier University Hospitals NHS Trust
OTHER
Barts & The London NHS Trust
OTHER
King's College Hospital NHS Trust
OTHER
Versus Arthritis (Funder)
UNKNOWN
University College, London
OTHER